Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME: Effect of Fluconazole on the Intestinal Microbiome
NCT07295314Phase 1Not yet recruiting
- Sponsor
- University of Amsterdam
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluconazole (2 arms), sponsored by University of Amsterdam. Primary endpoint: Effect of fluconazole on the intestinal microbiome at 14 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
fluconazole
Beyond the preview
Go deeper on NCT07295314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295314.